Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2011

Aug 12, 2011

34301_dirs_2011-08-12_0ac93145-f8c0-4541-93a4-85d009f90338.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2011-02-28

Reporting Person: HEDRICK MARC H (Director, President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-08-12 Common Stock P 100 $3.17 Acquired 4100 Indirect
2011-08-12 Common Stock P 500 $3.1793 Acquired 4600 Indirect
2011-08-12 Common Stock P 100 $3.1891 Acquired 4700 Indirect
2011-08-12 Common Stock P 200 $3.189 Acquired 4900 Indirect
2011-08-12 Common Stock P 1600 $3.19 Acquired 6500 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 7800 Indirect
Common Stock 485088 Direct